Crossref journal-article
Elsevier BV
Brain Research Reviews (78)
Bibliography

Reddy, P. H., & Beal, M. F. (2005). Are mitochondria critical in the pathogenesis of Alzheimer’s disease? Brain Research Reviews, 49(3), 618–632.

Authors 2
  1. P. Hemachandra Reddy (first)
  2. M. Flint Beal (additional)
References 158 Referenced 233
  1. 10.1083/jcb.200207030 / J. Cell Biol. / Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells by Anandatheerthavarada (2003)
  2. 10.1007/BF02290679 / Somatic Cell Mol. Genet. / Isolation, characterization, and mapping of gene encoding dihyrolipoylsuccinyltransferase (E2k) of human alpha-etoglutarate dehydrogenase complex by Ali (1994)
  3. 10.1179/016164103101201977 / Neurol. Res. / Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice by Aliev (2003)
  4. 10.1073/pnas.93.3.1314 / Proc. Natl. Acad. Sci. U. S. A. / Transfer of beta-amyloid Precursor protein gene using adenovirus vector causes mitochondrial abnormalities in cultured normal human muscle by Askanas (1996)
  5. 10.1016/S0005-2728(98)00114-5 / Biochim. Biophys. Acta / Mitochondrial dysfunction in neurodegenerative diseases by Beal (1998)
  6. 10.1038/nrn1386 / Nat. Rev., Neurosci. / Experimental therapeutics in transgenic mouse models of Huntington's disease by Beal (2004)
  7. 10.1007/s004410050955 / Cell. Tissue. Res. / Amyloid beta-protein toxicity and oxidative stress in Alzheimer's disease by Behl (1997)
  8. 10.1016/S0014-4886(03)00252-8 / Exp. Neurol. / Time sequence of maturation of dystrophic neurites associated with Abeta deposits in APP/PS1 transgenic mice by Blanchard (1997)
  9. 10.1002/hipo.1993.4500030708 / Hippocampus / Metabolic alterations common to neural and non-neural cells in Alzheimer's disease by Blass (1993)
  10. {'key': '10.1016/j.brainresrev.2005.03.004_bib10', 'series-title': "Alzheimer's Disease: Cause(s), Diagnosis, Treatment, and Care", 'first-page': '187', 'article-title': 'Cerebral metabolic impairments', 'author': 'Blass', 'year': '1997'} / Alzheimer's Disease: Cause(s), Diagnosis, Treatment, and Care / Cerebral metabolic impairments by Blass (1997)
  11. 10.1002/jnr.10087 / J. Neurosci. Res. / Brain metabolism and brain disease: is metabolic deficiency the proximate cause of Alzheimer dementia? by Blass (2001)
  12. {'key': '10.1016/j.brainresrev.2005.03.004_bib12', 'first-page': '513', 'article-title': "The role of oxidative abnormalities in the pathophysiology of Alzheimer's disease", 'volume': '147', 'author': 'Blass', 'year': '1991', 'journal-title': 'Rev. Neurol.'} / Rev. Neurol. / The role of oxidative abnormalities in the pathophysiology of Alzheimer's disease by Blass (1991)
  13. 10.1016/S0197-4580(01)00314-1 / Neurobiol. Aging / Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease by Bosetti (2002)
  14. 10.1093/emboj/17.1.37 / EMBO J. / Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization by Bossy-Wetzel (1998)
  15. 10.1016/0024-3205(95)00055-B / Life Sci. / Bioenergetic and oxidative stress in neurodegenerative diseases by Bowling (1995)
  16. 10.1002/ana.10232 / Ann. Neurol. / Succinate in dystrophic white matter: a proton magnetic resonance spectroscopy finding characteristic for complex II deficiency by Brockmann (2002)
  17. 10.1093/genetics/130.1.163 / Genetics / Mitochondrial DNA complex I and III mutations associated with Leber's hereditary optic neuropathy by Brown (1992)
  18. 10.1002/(SICI)1096-8628(19960122)61:3<283::AID-AJMG15>3.0.CO;2-P / Am. J. Med. Genet. / Mitochondrial DNA sequence analysis of four Alzheimer's and Parkinson's disease patients by Brown (1996)
  19. 10.1046/j.1471-4159.1998.71010281.x / J. Neurochem. / Metabolic dysfunction in familial, but not sporadic, amyotrophic lateral sclerosis by Browne (1998)
  20. 10.1016/S0896-6273(02)00604-9 / Neuron / Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome by Busciglio (2002)
  21. 10.1016/S1471-4914(01)02173-6 / Trends Mol. Med. / Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide by Butterfield (2001)
  22. 10.1007/BF00997071 / Metab. Brain Dis. / Thiamine-dependent enzyme changes in temporal cortex of patients with Alzheimer's disease by Butterworth (1995)
  23. 10.1111/j.1471-4159.2004.02438.x / J. Neurochem. / Mitochondrial dysfunction of Alzheimer's disease cybrids enhances Abeta toxicity by Cardoso (2004)
  24. 10.1046/j.0022-3042.2001.00681.x / J. Neurochem. / Beta-amyloid inhibits integrated mitochondrial respiration and key enzyme activities by Casley (2002)
  25. 10.1016/S0092-8674(00)81203-9 / Cell / Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease by Casari (1998)
  26. 10.1111/j.1601-5223.2001.00065.x / Hereditas / MtDNA mutations in maternally inherited diabetes: presence of the 3397 ND1 mutation previously associated with Alzheimer's and Parkinson's disease by Cavelier (2001)
  27. {'key': '10.1016/j.brainresrev.2005.03.004_bib27', 'first-page': '343', 'article-title': "Impairment in gene expression ox oxidative metabolism in vulnerable brain regions in Alzheimer's disease", 'volume': '14', 'author': 'Chandrasekaran', 'year': '1994', 'journal-title': 'Neurobiol. Aging'} / Neurobiol. Aging / Impairment in gene expression ox oxidative metabolism in vulnerable brain regions in Alzheimer's disease by Chandrasekaran (1994)
  28. 10.1006/exnr.1996.0180 / Exp. Neurol. / Evidence for physiological down-regulation of brain oxidative phosphorylation in Alzheimer's disease by Chandrasekharan (1996)
  29. 10.1016/S0169-328X(96)00191-X / Mol. Brain Res. / Decreased expression of nuclear and mitochondrial DNA-encoded genes of oxidative phosphorylation in association neocortex in Alzheimer disease by Chandrasekaran (1997)
  30. 10.1097/00001756-200109170-00017 / NeuroReport / Co-association of parkin and alpha-synuclein by Choi (2001)
  31. {'issue': 'Suppl. 3', 'key': '10.1016/j.brainresrev.2005.03.004_bib31', 'first-page': 'III15', 'article-title': "New insights into Parkinson's disease", 'volume': '250', 'author': 'Chung', 'year': '2003', 'journal-title': 'J. Neurol.'} / J. Neurol. / New insights into Parkinson's disease by Chung (2003)
  32. 10.1038/nn1372 / Nat. Neurosci. / Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function by Cleary (2005)
  33. 10.1038/ng1292-324 / Nat. Genet. / Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age by Corral-Debrinski (1992)
  34. 10.1073/pnas.0403649101 / Proc. Natl. Acad. Sci U. S. A. / Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication by Coskun (2004)
  35. 10.1523/JNEUROSCI.4276-04.2005 / J. Neurosci. / Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta1–42 by Crouch (2005)
  36. 10.1006/neur.1996.0060 / Neurodegeneration / Oxidative mechanisms in beta-amyloid cytotoxicity by Davis (1996)
  37. 10.1006/neur.1996.0056 / Neurodegeneration / Structural correlates of cognition in dementia: quantification and assessment of synapse change by Dekosky (1999)
  38. 10.1203/00006450-199412000-00004 / Pediatr. Res. / Aberrant splicing of exon 6 in the pyruvate dehydrogenase-E1 alpha mRNA linked to a silent mutation in a large family with Leigh's encephalomyelopathy by De Meirleir (1994)
  39. 10.1111/j.1365-2990.1997.tb01301.x / Neuropathol. Appl. Neurobiol. / Association of the mitochondrial tRNA(A4336G) mutation with Alzheimer's and Parkinson's diseases by Egensperger (1997)
  40. 10.1056/NEJM198307213090304 / N. Engl. J. Med. / Mitochondrial inheritance in a mitochondrially mediated disease by Egger (1983)
  41. {'key': '10.1016/j.brainresrev.2005.03.004_bib41', 'first-page': '1835', 'article-title': 'Intracellular ATP levels determine cell death fate by apoptosis or necrosis', 'volume': '57', 'author': 'Eguchi', 'year': '1997', 'journal-title': 'Cancer Res.'} / Cancer Res. / Intracellular ATP levels determine cell death fate by apoptosis or necrosis by Eguchi (1997)
  42. 10.1385/JMN:18:3:229 / J. Mol. Neurosci. / Mutant and wild-type alpha-synuclein interact with mitochondrial cytochrome c oxidase by Elkon (2002)
  43. 10.1016/0022-510X(96)00163-3 / J. Neurol. Sci. / The antioxidant enzymatic blood profile in Alzheimer's and vascular diseases. Their association and a possible assay to differentiate demented subjects and controls by Famulari (1996)
  44. 10.1172/JCI200420138 / J. Clin. Invest. / Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport by Ferreirinha (2004)
  45. 10.1126/science.278.5337.407 / Science / Genetics of aging by Finch (1997)
  46. 10.1038/35041687 / Nature / Oxidants, oxidative stress and the biology of ageing by Finkel (2000)
  47. 10.1007/s007020050099 / J. Neural Transm. / Abnormalities of mitochondrial enzymes in Alzheimer's disease by Gibson (1998)
  48. 10.1016/S0925-4439(00)00057-0 / Biochim. Biophys. Acta / Differential alterations in antioxidant capacity in cells from Alzheimer patients by Gibson (2000)
  49. {'key': '10.1016/j.brainresrev.2005.03.004_bib49', 'first-page': '21', 'article-title': "Evidence for neuronal oxidative damage in Alzheimer's disease", 'volume': '149', 'author': 'Good', 'year': '1996', 'journal-title': 'Am. J. Pathol.'} / Am. J. Pathol. / Evidence for neuronal oxidative damage in Alzheimer's disease by Good (1996)
  50. 10.1126/science.1099320 / Science / The pathophysiology of mitochondrial cell death by Green (2004)
  51. 10.1126/science.281.5381.1309 / Science / Mitochondria and apoptosis by Green (1998)
  52. 10.1086/339935 / Am. J. Hum. Genet. / Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial chaperonin Hsp60 by Hansen (2002)
  53. 10.1523/JNEUROSCI.21-09-03017.2001 / J. Neurosci. / Mitochondrial abnormalities in Alzheimer's disease by Hirai (2001)
  54. 10.1074/jbc.M201154200 / J. Biol. Chem. / The C66W mutation in the deafness dystonia peptide 1 (DDP1) affects the formation of functional DDP1.TIM13 complexes in the mitochondrial intermembrane space by Hofmann (2002)
  55. 10.1192/bjp.180.2.131 / Br. J. Psychiatry / Genotype and phenotypes in Alzheimer's disease by Holmes (2002)
  56. {'key': '10.1016/j.brainresrev.2005.03.004_bib56', 'first-page': '428', 'article-title': 'A new mitochondrial disease associated with mitochondrial DNA heteroplasmy', 'volume': '46', 'author': 'Holt', 'year': '1990', 'journal-title': 'Am. J. Hum. Genet.'} / Am. J. Hum. Genet. / A new mitochondrial disease associated with mitochondrial DNA heteroplasmy by Holt (1990)
  57. 10.1111/j.1600-0404.1996.tb05868.x / Acta Neurol. Scand., Suppl. / Oxidative metabolism deficiencies in brains of patients with Alzheimer's disease by Hoyer (1996)
  58. {'key': '10.1016/j.brainresrev.2005.03.004_bib58', 'first-page': '11', 'article-title': "Models of Alzheimer's disease: cellular and molecular aspects", 'volume': '49', 'author': 'Hoyer', 'year': '1997', 'journal-title': 'J. Neural Transm., Suppl.'} / J. Neural Transm., Suppl. / Models of Alzheimer's disease: cellular and molecular aspects by Hoyer (1997)
  59. 10.1016/S0925-4439(02)00222-3 / Biochim. Biophys. Acta / Inhibition of the alpha-ketoglutarate dehydrogenase complex alters mitochondrial function and cellular calcium regulation by Huang (2003)
  60. 10.1073/pnas.92.15.6892 / Proc. Natl. Acad. Sci. U. S. A. / A mitochondrial DNA clone is associated with increased risk for Alzheimer disease by Hutchin (1995)
  61. 10.1007/BF01291887 / J. Neural Transm. / Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Alzheimer's disease by Jimenez-Jimenez (1997)
  62. 10.1038/sj.mp.4000926 / Mol. Psychiatry / The other forgotten genome: mitochondrial DNA and mental disorders by Kato (2001)
  63. 10.1523/JNEUROSCI.18-12-04439.1998 / J. Neurosci. / Increased sensitivity to mitochondrial toxin-induced apoptosis in neural cells expressing mutant presenilin-1 is linked to perturbed calcium homeostasis and enhanced oxyradical production by Keller (1998)
  64. 10.1002/1531-8249(200008)48:2<148::AID-ANA3>3.0.CO;2-7 / Ann. Neurol. / Alzheimer's disease cybrids replicate beta-amyloid abnormalities through cell death pathways by Khan (2000)
  65. 10.1097/00001756-200210280-00032 / NeuroReport / Amyloid beta peptide induces cytochrome c release from isolated mitochondria by Kim (2002)
  66. 10.1002/ana.10687 / Ann. Neurol. / Low mutant load of mitochondrial DNA G13513A mutation can cause Leigh's disease by Kirby (2003)
  67. 10.1111/j.1471-4159.1992.tb09439.x / J. Neurochem. / Brain cytochrome oxidase in Alzheimer's disease by Kish (1992)
  68. 10.1006/exnr.1999.7190 / Exp. Neurol. / ALS-linked Cu/Zn-SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis by Kruman (1999)
  69. 10.1074/jbc.M105326200 / J. Biol. Chem. / Formation and removal of alpha-synuclein aggregates in cells exposed to mitochondrial inhibitors by Lee (2002)
  70. 10.1016/j.cell.2004.11.003 / Cell / The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses by Li (2004)
  71. 10.1016/S0006-291X(05)80136-6 / Biochem. Biophys. Res. Commun. / Detection of point mutations in codon 331 of mitochondrial NADH dehydrogenase subunit 2 in Alzheimer's brains by Lin (1992)
  72. 10.1093/hmg/11.2.133 / Hum. Mol. Genet. / High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain by Lin (2002)
  73. 10.1016/j.freeradbiomed.2004.11.005 / Free Radical Biol. Med. / Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations by Liu (2005)
  74. 10.1212/WNL.45.8.1594 / Neurology / Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease by Lovell (1995)
  75. 10.1016/S0197-4580(97)00108-5 / Neurobiol. Aging / Elevated 4-hydroynonenal in ventricular fluids in Alzheimer's disease by Lovell (1997)
  76. 10.1212/WNL.51.6.1562 / Neurology / Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease by Lovell (1998)
  77. 10.1172/JCI119481 / J. Clin. Invest. / Excessive formation of hydroxyl radicals and aldehydic lipid peroxidation products in cultured skin fibroblasts from patients with complex I deficiency by Luo (1997)
  78. 10.1126/science.1091230 / Science / ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease by Lustbader (2004)
  79. 10.1073/pnas.95.11.6004 / Proc. Natl. Acad. Sci. U. S. A. / Localization of the Wilson's disease protein product to mitochondria by Lutsenko (1998)
  80. 10.1046/j.1471-4159.1997.68052061.x / J. Neurochem. / An assessment of oxidative damage to protein, lipids, and DNA in brain from patients with Alzheimer's disease by Lyras (1997)
  81. 10.1046/j.1471-4159.1998.71010302.x / J. Neurochem. / Oxidative damage to proteins, lipids, and antioxidant enzyme regions from patients with dementia with Lewy bodies by Lyras (1998)
  82. 10.1385/NMM:5:2:147 / Neuromol. Med. / Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage by Manczak (2004)
  83. 10.1111/j.1471-4159.2004.02884.x / J. Neurochem. / Time-course of mitochondrial gene expressions in mice brains: implications for mitochondrial dysfunction, oxidative damage, cytochrome c release in aging by Manczak (2005)
  84. 10.1016/j.neurobiolaging.2003.04.007 / Neurobiol. Aging / Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses by Mandelkow (2003)
  85. 10.1083/jcb.200401085 / J. Cell Biol. / MARK/PAR1 kinase is a regulator of microtubule-dependent transport in axons by Mandelkow (2004)
  86. 10.1016/S0891-5849(96)00629-6 / Free Radical Biol. Med. / Oxidative stress hypothesis in Alzheimer's disease by Markesbery (1998)
  87. 10.1001/archneur.56.12.1449 / Arch. Neurol. / The role of oxidative stress in Alzheimer's disease by Markesbery (1999)
  88. 10.1111/j.1750-3639.1999.tb00215.x / Brain Pathol. / Oxidative alterations in Alzheimer's disease by Markesbery (1999)
  89. 10.1074/jbc.M212265200 / J. Biol. Chem. / Neurotoxic mechanisms caused by the Alzheimer's disease-linked Swedish amyloid precursor protein by Marques (2003)
  90. 10.1007/s004390050449 / Hum. Genet. / Biochemical and genetic studies of four patients with pyruvate dehydrogenase E1 alpha deficiency by Marsac (2003)
  91. 10.1111/j.1471-4159.1993.tb07436.x / J. Neurochem. / Brain α-ketoglutarate dehydrogenase activity in Alzheimer's disease by Mastrogiacomo (1994)
  92. 10.1016/S0006-8993(98)00763-X / Brain Res. / Amyloid beta-peptide induces apoptosis-related events in synapses and dendrites by Mattson (1998)
  93. 10.1042/bss0670151 / Biochem. Soc. Symp. / Perturbed endoplasmic reticulum function, synaptic apoptosis and the pathogenesis of Alzheimer's disease by Mattson (2001)
  94. 10.1002/ana.410360510 / Ann. Neurol. / Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease by Mecocci (1994)
  95. 10.1002/ana.410440322 / Ann. Neurol. / Cerebrospinal fluid F2-isopronelevels are increased in Alzheimer's disease by Montine (1998)
  96. 10.1111/j.1432-1033.1994.tb20010.x / Eur. J. Biochem. / Isolation, characterization, and structural organization of the gene and pseudogene for the dihyrolipoyl sucinyltransferase component of the human 2-oxoglutarate dehydrogenase complex by Nakano (1994)
  97. 10.1002/ana.410320703 / Ann. Neurol. / An introduction to the free radical hypothesis in Parkinson's disease by Olanow (1992)
  98. 10.1212/WNL.40.8.1302 / Neurology / Cytochrome oxidase deficiency in Alzheimer's disease by Parker (1990)
  99. 10.1212/WNL.44.6.1090 / Neurology / Electron transport chain defects in Alzheimer's disease brain by Parker (1994)
  100. 10.1016/S0925-4439(03)00127-3 / Biochim. Biophys. Acta / Functional alteration of cytochrome c oxidase by SURF1 mutations in Leigh syndrome by Pecina (2003)
  101. 10.1016/0304-3940(80)90220-7 / Neurosci. Lett. / Coenzyme A acetylating enzymes in Alzheimer's disease: possible cholinergic ‘compartment’ of pyruvate dehydrogenase by Perry (1998)
  102. 10.1097/00001756-199908020-00035 / NeuroReport / Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation by Perry (1999)
  103. 10.1212/01.WNL.0000080363.10902.E9 / Neurology / Atypical Leigh syndrome associated with the D393N mutation in the mitochondrial ND5 subunit by Petruzzella (2003)
  104. 10.1172/JCI118798 / J. Clin. Invest. / Mitochondrial complex I deficiency leads to increased production of superoxide radicals and induction of superoxide dismutase by Pitkanen (1996)
  105. 10.1203/00006450-199603000-00021 / Pediatr. Res. / Familial cardiomyopathy with cataracts and lactic acidosis: a defect in complex I (NADH-dehydrogenase) of the mitochondria respiratory chain by Pitkanen (1996)
  106. 10.1016/0140-6736(93)91705-Q / Lancet / Apolipoprotein E polymorphism and Alzheimer's disease by Poirier (1993)
  107. 10.1073/pnas.95.7.3449 / Proc. Natl. Acad. Sci. U. S. A. / IPF2alpha-I: an index of lipid peroxidation in humans by Pratico (1998)
  108. 10.1523/JNEUROSCI.21-12-04183.2001 / J. Neurosci. / Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis by Pratico (2001)
  109. 10.1038/84818 / Nat. Genet. / Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits by Puccio (2001)
  110. 10.1093/hmg/ddh140 / Hum. Mol. Genet. / Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: upregulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease by Reddy (2004)
  111. 10.3233/JAD-2005-7203 / J. Alzheimer's Dis. / Differential loss of synaptic proteins in Alzheimer's disease patients: implications to synaptic damage by Reddy (2005)
  112. 10.1056/NEJM199603213341202 / N. Engl. J. Med. / Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E by Reiman (1996)
  113. 10.1016/j.cell.2004.05.008 / Cell / Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain by Ricci (2004)
  114. 10.1093/hmg/ddh217 / Hum. Mol. Genet. / The calcium-binding aspartate/glutamate carriers, citrin and aralar1, are new substrates for the DDP1/TIMM8a–TIMM13 complex by Roesch (2004)
  115. 10.1146/annurev.med.47.1.387 / Annu. Rev. Med. / Apolipoprotein E alleles risk factors in Alzheimer's disease by Roses (1996)
  116. 10.1046/j.1471-4159.1997.68052092.x / J. Neurochem. / 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease by Sayree (1997)
  117. 10.1046/j.1365-2362.1999.00540.x / Eur. J. Clin. Invest. / Mitochondrial myopathies and encephalomyopathies by Schapira (1999)
  118. 10.1074/jbc.271.50.31763 / J. Biol. Chem. / The protein import system of mitochondria by Schatz (1996)
  119. 10.1073/pnas.90.20.9649 / Proc. Natl. Acad. Sci. U. S. A. / Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late onset Alzheimer's disease by Schmechel (1993)
  120. 10.1016/j.bbrc.2003.09.037 / Biochem. Biophys. Res. Commun. / New patterns of inheritance in mitochondrial disease by Schwartz (2003)
  121. 10.1152/physrev.2001.81.2.741 / Physiol. Rev. / Alzheimer's disease: genes, proteins, and therapy by Selkoe (2001)
  122. 10.1523/JNEUROSCI.17-12-04612.1997 / J. Neurosci. / Calcium homeostasis and reactive oxygen species production in cells transformed by mitochondria from individuals with sporadic Alzheimer's disease by Sheehan (1997)
  123. {'issue': 'Suppl. 1', 'key': '10.1016/j.brainresrev.2005.03.004_bib123', 'first-page': 'S10', 'article-title': "A gene locus of dihyrolipoyl sucinyltransferase (DLST) is associated with Alzheimer's disease", 'volume': '66', 'author': 'Sheu', 'year': '1996', 'journal-title': 'J. Neurochem.'} / J. Neurochem. / A gene locus of dihyrolipoyl sucinyltransferase (DLST) is associated with Alzheimer's disease by Sheu (1996)
  124. {'key': '10.1016/j.brainresrev.2005.03.004_bib124', 'first-page': 'S2', 'article-title': 'α-Ketoacid dehydrogenase complexes in inborn errors of metabolism and neurodegeneration', 'volume': '69', 'author': 'Sheu', 'year': '1997', 'journal-title': 'J. Neurochem.'} / J. Neurochem. / α-Ketoacid dehydrogenase complexes in inborn errors of metabolism and neurodegeneration by Sheu (1997)
  125. 10.1046/j.1471-4159.1998.70031143.x / J. Neurochem. / Immunochemical characterization of the deficiency of the alpha-ketoglutarate dehydrogenase complex in thiamine-deficient rat brain by Sheu (1998)
  126. 10.1073/pnas.91.23.10771 / Proc. Natl. Acad. Sci. U. S. A. / Oxidative damage and mitochondrial decay in aging by Shigenaga (1994)
  127. 10.1007/s100480050002 / Neurogenetics / Oxidative phosphorylation defects and Alzheimer's disease by Shoffner (1997)
  128. 10.1006/geno.1993.1299 / Genomics / Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients by Shoffner (1993)
  129. 10.1097/00005072-199409000-00010 / J. Neuropathol. Exp. Neurol. / Functional alterations in Alzheimer's disease: selective loss of mitochondrial-encoded cytochrome oxidase mRNA in the hippocampal formation by Simonian (1994)
  130. 10.1001/jama.273.12.942 / JAMA / Apolipoprotein E type 4 allele andcerebral glucose metabolism in relatives at risk for familial Alzheimer disease by Small (1995)
  131. 10.1038/35086072 / Nat. Rev., Neurosci. / Alzheimer's disease and Abeta toxicity: from top to bottom by Small (2001)
  132. 10.1073/pnas.88.23.10540 / Proc. Natl. Acad. Sci. U. S. A. / Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer's disease by Smith (1991)
  133. 10.1007/BF02815203 / Mol. Chem. Neuropathol. / Oxidative posttranslational modifications in Alzheimer disease. A possible pathogenic role in the formation of senile plaques and neurofibrillary tangles by Smith (1996)
  134. 10.1046/j.1471-4159.1998.70052212.x / J. Neurochem. / Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress by Smith (1998)
  135. 10.1089/15230860050192198 / Antioxid. Redox Signal / Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease by Smith (2000)
  136. 10.1016/S0197-0186(01)00123-1 / Neurochem. Int. / Amyloid-beta, tau alterations and mitochondrial dysfunction in Alzheimer disease: the chickens or the eggs? by Smith (2002)
  137. 10.1083/jcb.200108057 / J. Cell Biol. / Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress by Stamer (2002)
  138. 10.1523/JNEUROSCI.1899-04.2004 / J. Neurosci. / Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species by Starkov (2004)
  139. 10.1016/S0306-4522(03)00037-X / Neuroscience / Regional brain cytochrome oxidase activity in beta-amyloid precursor protein transgenic mice with the Swedish mutation by Strazielle (2003)
  140. 10.1016/S0969-9961(02)00019-0 / Neurobiol. Dis. / Fas and Fas ligand are associated with neuritic degeneration in the AD brain and participate in beta-amyloid-induced neuronal death by Su (2003)
  141. 10.1016/j.mehy.2003.12.045 / Med. Hypotheses / A “mitochondrial cascade hypothesis” for sporadic Alzheimer's disease by Swerdlow (2004)
  142. 10.1212/WNL.49.4.918 / Neurology / Cybrids in Alzheimer's disease: a cellular model of the disease? by Swerdlow (1997)
  143. 10.1046/j.1471-4159.2000.0751234.x / J. Neurochem. / In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification by Takeda (2000)
  144. 10.1016/S0024-3205(96)00583-8 / Life Sci. / Oxidative-stress associated parameters (lactoferrin, superoxide dismutases) in serum of patients with Alzheimer's disease by Thome (1997)
  145. 10.1016/S0896-6273(01)00476-7 / Neuron / New frontiers in Alzheimer's disease genetics by Tanzi (2001)
  146. 10.1016/j.cell.2005.02.008 / Cell / Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective by Tanzi (2005)
  147. 10.1002/ana.410300410 / Ann. Neurol. / Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment by Terry (1991)
  148. 10.1016/j.nbd.2003.09.011 / Neurobiol. Dis. / Mitochondrial abnormalities in cybrid cell models of sporadic Alzheimer's disease worsen with passage in culture by Trimmer (2004)
  149. 10.1073/pnas.91.18.8334 / Proc. Natl. Acad. Sci. U. S. A. / Cytoplasmic transfer of the mtDNA nt 8993 T-(G (ATP6) point mutation associated with Leigh syndrome into mtDNA-less cells demonstrates cosegregation with a decrease in state III respiration and ADP/O ratio by Trounce (1994)
  150. 10.1055/s-2003-39607 / Neuropediatrics / Leigh syndrome with cytochrome-c oxidase deficiency and a single T insertion nt 5537 in the mitochondrial tRNATrp gene by Tulinius (2003)
  151. 10.1136/jmg.33.12.1002 / J. Med. Genet. / The tRNA(Gln) 4336 mitochondrial DNA variant is not a high penetrance mutation which predisposes to dementia before the age of 75 years by Tysoe (1996)
  152. 10.1002/ajmg.a.10202 / Am. J. Med. Genet. / Homozygous Gly555Glu mutation in the nuclear-encoded 70 kDa flavoprotein gene causes instability of the respiratory chain complex II by Van Coster (2003)
  153. 10.1111/j.1471-4159.1990.tb04948.x / J. Neurochem. / Enzyme activities in relation to pH and lactate in post-mortem brain in Alzheimer-type and other dementias by Yates (1990)
  154. 10.1016/j.bbrc.2003.11.056 / Biochem. Biophys. Res. Commun. / Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition by Yokota (2003)
  155. 10.1126/science.283.5407.1482 / Science / Mitochondrial diseases in man and mouse by Wallace (1999)
  156. 10.1038/416535a / Nature / Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo by Walsh (2002)
  157. 10.1097/00005768-200301000-00017 / Med. Sci. Sports Exercise / The cellular energy crisis: mitochondria and cell death by Waterhouse (2003)
  158. 10.1006/mgme.2001.3206 / Mol. Genet. Metab. / A novel mutation in SURF1 causes skipping of exon 8 in a patient with cytochrome c oxidase-deficient leigh syndrome and hypertrichosis by Williams (2001)
Dates
Type When
Created 20 years, 4 months ago (April 20, 2005, 7:28 a.m.)
Deposited 1 year, 7 months ago (Jan. 24, 2024, 9:59 p.m.)
Indexed 1 week, 1 day ago (Aug. 26, 2025, 3:12 a.m.)
Issued 19 years, 10 months ago (Nov. 1, 2005)
Published 19 years, 10 months ago (Nov. 1, 2005)
Published Print 19 years, 10 months ago (Nov. 1, 2005)
Funders 0

None

@article{Reddy_2005, title={Are mitochondria critical in the pathogenesis of Alzheimer’s disease?}, volume={49}, ISSN={0165-0173}, url={http://dx.doi.org/10.1016/j.brainresrev.2005.03.004}, DOI={10.1016/j.brainresrev.2005.03.004}, number={3}, journal={Brain Research Reviews}, publisher={Elsevier BV}, author={Reddy, P. Hemachandra and Beal, M. Flint}, year={2005}, month=nov, pages={618–632} }